Just how much money do drugmakers gain from patent extensions?; Rollout of Covid vaccines is bumpy, but not unexpected

Taking stock of the drug industry, from the lab to the medicine chest

September 26, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Just how much money do drugmakers gain from patent extensions? Four blockbuster drugs — Humira, Avastin, Rituxan, and Lantus — made 56% of their overall revenue after the end of their initial patents. By Annalisa Merelli Rollout of Covid vaccines is bumpy, but not unexpected, experts say Reality sets in with vaccine launch not part of a government emergency response. Insurance issues mount, prices rise, demand up for Covid booster shots. By Helen Branswell STAT+ | Intercept, once a biotech trailblazer, sells itself for less than $1 billion Alfasigma, an Italian pharmaceutical firm, will pay $19 a share for Intercept, in a roughly $800 million cash deal. By Damian Garde JUAN MABROMATA/AFP via Getty Images STAT+ | Opinion: The problem with potential changes to the biosimilar regulatory framework Legislative proposals risk patient safety and the provider and patient confidence required for the future of the biosimilar marketplace. By Leah Christl STAT+ | Ionis inches toward first solo drug launch with late-stage trial success for rare genetic disease therapy The California biotech said its drug olezarsen had success in treating FCS, a rare and serious disease that prevents the body from breaking down fats. By Jonathan Wosen STAT+ | Early data are promising for autoimmune disease drug from Roivant Sciences' Immunovant The drug, from Roivant's Immunovant, reduced the levels of a key immune marker in the blood, a promising signal. By Andrew Joseph

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser